Annual EBIT
-$454.69 M
-$100.92 M-28.53%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual earnings before interest & taxes is -$454.69 million, with the most recent change of -$100.92 million (-28.53%) on December 31, 2023.
- During the last 3 years, IBRX annual EBIT has fallen by -$237.74 million (-109.58%).
- IBRX annual EBIT is now -194.60% below its all-time high of -$154.34 million, reached on December 31, 2019.
Performance
IBRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$45.51 M
+$50.06 M+52.38%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly earnings before interest & taxes is -$45.51 million, with the most recent change of +$50.06 million (+52.38%) on September 30, 2024.
- Over the past year, IBRX quarterly EBIT has increased by +$50.06 million (+52.38%).
- IBRX quarterly EBIT is now -28.11% below its all-time high of -$35.52 million, reached on March 31, 2020.
Performance
IBRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$439.04 M
+$15.12 M+3.33%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM earnings before interest & taxes is -$439.04 million, with the most recent change of +$15.12 million (+3.33%) on September 30, 2024.
- Over the past year, IBRX TTM EBIT has increased by +$15.12 million (+3.33%).
- IBRX TTM EBIT is now -1136.04% below its all-time high of -$35.52 million, reached on March 31, 2020.
Performance
IBRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IBRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.5% | +52.4% | +3.3% |
| 3 y3 years | -109.6% | +57.1% | -19.7% |
| 5 y5 years | -194.6% | +57.1% | -19.7% |
IBRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.7% | at low | at high | +77.4% | -31.8% | +5.5% |
| 5 y | 5-year | -194.6% | at low | -28.1% | +77.4% | -1136.0% | +5.5% |
| alltime | all time | -194.6% | at low | -28.1% | +77.4% | -1136.0% | +5.5% |
ImmunityBio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$45.51 M(-52.4%) | -$439.04 M(-3.3%) |
| Jun 2024 | - | -$95.56 M(-1.1%) | -$454.16 M(-2.2%) |
| Mar 2024 | - | -$96.64 M(-52.0%) | -$464.57 M(+2.2%) |
| Dec 2023 | -$454.69 M(+28.5%) | -$201.33 M(+232.1%) | -$454.69 M(+36.5%) |
| Sep 2023 | - | -$60.62 M(-42.8%) | -$333.10 M(-9.2%) |
| Jun 2023 | - | -$105.98 M(+22.1%) | -$366.87 M(+6.0%) |
| Mar 2023 | - | -$86.77 M(+8.8%) | -$346.03 M(-2.2%) |
| Dec 2022 | -$353.77 M | -$79.73 M(-15.5%) | -$353.79 M(-2.0%) |
| Sep 2022 | - | -$94.40 M(+10.9%) | -$361.12 M(+2.7%) |
| Jun 2022 | - | -$85.14 M(-9.9%) | -$351.54 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$94.53 M(+8.6%) | -$352.21 M(+5.1%) |
| Dec 2021 | -$334.99 M(+54.4%) | -$87.06 M(+2.6%) | -$334.99 M(+6.7%) |
| Sep 2021 | - | -$84.81 M(-1.2%) | -$313.87 M(+6.5%) |
| Jun 2021 | - | -$85.81 M(+11.0%) | -$294.70 M(+13.9%) |
| Mar 2021 | - | -$77.31 M(+17.2%) | -$258.75 M(+19.3%) |
| Dec 2020 | -$216.96 M(+40.6%) | -$65.95 M(+0.5%) | -$216.96 M(+43.7%) |
| Sep 2020 | - | -$65.64 M(+31.7%) | -$151.01 M(+76.9%) |
| Jun 2020 | - | -$49.85 M(+40.3%) | -$85.37 M(+140.3%) |
| Mar 2020 | - | -$35.52 M | -$35.52 M |
| Dec 2019 | -$154.34 M | - | - |
FAQ
- What is ImmunityBio annual earnings before interest & taxes?
- What is the all time high annual EBIT for ImmunityBio?
- What is ImmunityBio annual EBIT year-on-year change?
- What is ImmunityBio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ImmunityBio?
- What is ImmunityBio quarterly EBIT year-on-year change?
- What is ImmunityBio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ImmunityBio?
- What is ImmunityBio TTM EBIT year-on-year change?
What is ImmunityBio annual earnings before interest & taxes?
The current annual EBIT of IBRX is -$454.69 M
What is the all time high annual EBIT for ImmunityBio?
ImmunityBio all-time high annual earnings before interest & taxes is -$154.34 M
What is ImmunityBio annual EBIT year-on-year change?
Over the past year, IBRX annual earnings before interest & taxes has changed by -$100.92 M (-28.53%)
What is ImmunityBio quarterly earnings before interest & taxes?
The current quarterly EBIT of IBRX is -$45.51 M
What is the all time high quarterly EBIT for ImmunityBio?
ImmunityBio all-time high quarterly earnings before interest & taxes is -$35.52 M
What is ImmunityBio quarterly EBIT year-on-year change?
Over the past year, IBRX quarterly earnings before interest & taxes has changed by +$50.06 M (+52.38%)
What is ImmunityBio TTM earnings before interest & taxes?
The current TTM EBIT of IBRX is -$439.04 M
What is the all time high TTM EBIT for ImmunityBio?
ImmunityBio all-time high TTM earnings before interest & taxes is -$35.52 M
What is ImmunityBio TTM EBIT year-on-year change?
Over the past year, IBRX TTM earnings before interest & taxes has changed by +$15.12 M (+3.33%)